BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 10435388)

  • 1. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
    Rush CR; Baker RW; Wright K
    Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
    Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
    J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
    Rush CR; Griffiths RR
    J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects in humans after repeated administrations of zolpidem and triazolam.
    Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
    Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
    Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
    J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteers.
    Rush CR; Madakasira S; Hayes CA; Johnson CA; Goldman NH; Pazzaglia PJ
    Psychopharmacology (Berl); 1997 May; 131(1):9-18. PubMed ID: 9181630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
    Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
    Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolam and zolpidem: effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task.
    Rush CR; Baker RW
    Hum Psychopharmacol; 2001 Mar; 16(2):147-157. PubMed ID: 12404585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
    Mintzer MZ; Frey JM; Griffiths RR
    Behav Pharmacol; 1998 Nov; 9(7):545-59. PubMed ID: 9862080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedative, memory, and performance effects of hypnotics.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
    Morgan PT; Kehne JH; Sprenger KJ; Malison RT
    J Sleep Res; 2010 Mar; 19(1 Pt 2):157-64. PubMed ID: 19682231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abuse potential of zolpidem administered alone and with alcohol.
    Wilkinson CJ
    Pharmacol Biochem Behav; 1998 May; 60(1):193-202. PubMed ID: 9610942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.